6
Oct
2026

YPSOMED

Exhibitor at CPHI Milan 2026 stand 11F33, Packaging & Drug Delivery
About Us

Ypsomed is the leading developer and manufacturer of injection systems for the self-administration of liquid injectable medications. As the reliable partner of pharmaceutical and biotech companies for more than 40 years, Ypsomed provides tailored selfcare solutions to meet specific needs. Backed by a proven track record, Ypsomed offers the most comprehensive and innovative platform portfolio for pens, autoinjectors, and on-body devices. Delivered with best-in-class execution and ready to integrate with digital health services, these solutions help simplify therapy and improve the quality of life for millions of people living with chronic conditions. Ypsomed is headquartered in Burgdorf, Switzerland, and operates a global network of manufacturing facilities. More than 2,000 employees worldwide are committed every day to making selfcare simpler and easier.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Switzerland
  • Founded:
    1984
  • On CPHI since:
    2015
  • Certificates:
    4
  • Employees:
    1000 - 4999
Company types
Manufacturer/Innovator
Primary activities
Contract Manufacturer
Medical Devices
Packaging & drug delivery
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 11F33, Packaging & Drug Delivery

Products Featured at CPHI Milan 2026

  • YpsoLoop

    Product YpsoLoop

    Uniting sustainability and patient convenience: YpsoLoop is a paradigm-shifting circular solution. It provides the convenience of a pre-filled, two-step, single-use device, while enabling material recovery through a design made for automated disassembly and efficient recycling. All of this is backed b...
  • Autoinjectors

    Product Autoinjectors

    Ypsomed’s autoinjector systems are automated disposable injection devices for 1ml and 2.25ml filled glass or polymer syringes suitable for all patient groups. The Ypsomed autoinjector family is typically used for the growing range of infrequently injected antibody-based drugs.Ypsomed’s autoinjector platfor...
  • Pen injectors (prefilled and reusable)

    Product Pen injectors (prefilled and reusable)

     A pen injector is designed to support safe and effective self-injection, especially for people who require frequent dosing. It uses a pre-filled cartridge—usually 1.5 mL or 3 mL—typically containing a preserved drug solution that remains stable throughout the therapy duration. Pen injectors are avail...
  • YpsoFlow

    Product YpsoFlow

    YpsoFlow: The spring-driven pre-filled pen

    Offering trusted usability and a smooth path to market.

    YpsoFlow is a spring-driven, pre-filled pen platform for GLP-1 and peptide therapies, delivering doses up to 0.80 mL with a low-force mechanism and end-of-dos...
  • CliniPilot

    Product CliniPilot

    Ypsomed’s CliniPilot is an innovative add-on technology available in two versions, for YpsoMate 1 mL and 2.25 mL autoinjectors, transforming them into smart, connected devices, enabling connected clinical trials. It automatically captures and securely transmits key injection data—including time, date,...

Ypsomed AG Resources (1)

  • YpsoMate: The 2-step autoinjector

    Brochure YpsoMate: The 2-step autoinjector

    The YpsoMate autoinjector is an automated injection device for 1 mL long pre-filled glass or polymer syringes suitable for all patient groups. The device is triggered by push-on-skin activation which is convenient, ergonomic and preferred by patients.The design can be customised for individual dosing requirements.